Cannabinoid nanoemulsions have gained in popularity.
But are they safe and have they slipped through the regulatory cracks? Is this another example of a lesson (not) learned?
As recently as 2018, cultivation- and retail-sector financing was almost exclusively the domain of private companies, according to data from the Viridian Deal Tracker. But public debt financing has been taking a bigger role recently.
That trend is likely to continue as the United States moves toward federal legalization of some form, though how quickly it occurs remains up in the air.